Article
NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells
10 Apr 2024
Abstract excerpt
Triple-negative breast cancer (TNBC) is a very aggressive and heterogeneous group of tumors. In order to develop effective therapeutic strategies, it is therefore essential to identify the subtype-specific molecular mechanisms underlying disease progression and resistance to chemotherapy. TNBC cells are highly dependent on exogenous cystine, provided by overexpression of the cystine/glutamate antiporter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
